Organogenesis Holdings Inc. Class A Common Stock (ORGO) is a publicly traded Healthcare sector company. As of August 24, 2026, ORGO trades at $1.80 with a market cap of $231.61M and a P/E ratio of -2.20. ORGO moved -2.17% today. Year to date, ORGO is -65.25%; over the trailing twelve months it is -59.73%. Its 52-week range spans $1.54 to $7.08. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces ORGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Organogenesis Holdings Inc. Class A Common Stock (ORGO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ORGO moved -2.17% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $1.80 |
| Market Cap | $231.61M |
| P/E Ratio | -2.20 |
| EPS | $-0.82 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.08 |
| 52-Week Low | $1.54 |
| Volume | 462.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $457.45M |
| Net Income | $-84.16M |
| Gross Margin | 0.00% |
2 analysts cover ORGO: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.